Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. (Q33398933)

26 July 2017

Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. (English)

1 reference

Yersinia pseudotuberculosis

26 July 2017

0 references

vector-borne disease

0 references

Lactococcus lactis

object named as

Lactococcus lactis

1 reference

Florent Sebbane

2

0 references

Catherine Daniel

object named as

Catherine Daniel

1

0 references

author name string

Sabine Poiret

3

1 reference

26 July 2017

Denise Goudercourt

4

1 reference

26 July 2017

Joelle Dewulf

5

1 reference

26 July 2017

Chantal Mullet

6

1 reference

26 July 2017

Michel Simonet

7

1 reference

26 July 2017

Bruno Pot

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

9 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

27

1 reference

26 July 2017

8

1 reference

26 July 2017

1141-1144

1 reference

Immune defense against pneumonic plague

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

An antigen determining virulence in Pasteurella pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

The Yersinia Ysc-Yop 'type III' weaponry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

7 January 2021

Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

7 January 2021

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

7 January 2021

Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.022

7 January 2021

10.1016/J.VACCINE.2008.12.022

Identifiers

DOI

1 reference

26 July 2017

1 reference